Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5767067 | EMD SERONO | Follicle stimulating hormone and pharmaceutical compositions containing same |
Jun, 2015
(8 years ago) | |
US5767251 | EMD SERONO | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(8 years ago) |
Gonal-F Rff is owned by Emd Serono.
Gonal-F Rff contains Follitropin Alfa/Beta.
Gonal-F Rff has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Gonal-F Rff are:
Gonal-F Rff was authorised for market use on 25 March, 2004.
Gonal-F Rff is available in injectable;subcutaneous dosage forms.
The generics of Gonal-F Rff are possible to be released after 16 June, 2015.
Drugs and Companies using FOLLITROPIN ALFA/BETA ingredient
Market Authorisation Date: 25 March, 2004
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS